Atlas Trials

Validation of TERA Bio Station T101 of COVID-19 Tested Population.

Clinical trial NCT05088902 · UNKNOWN

Trial details

NCT number
NCT05088902
Sponsor
Tera Group
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID-19
Start date
2021-10-22
Primary completion
2022-03-06
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.